Pharmacogenomics Market Size, Share, Analysis — Forecasts To 2025

1
GLOBAL MARKET ESTIMATES RESEARCH
CONSULTANTS Ankita Roy, Treesha Banerjee and
Liza Dsouza from Global Market Estimates throw
the spotlight on the growing Pharmacogenomics
Market. The market report is designed to provide
a complete view on the global pharmacogenomics
market. This business intelligence report has
been categorised into qualitative and
quantitative insights over the forecast period
(2017-2025). The demand and supply matrix
section falls under the qualitative information
category, wherein, the market dynamics for
pharmacogenomics has been studied considering a
short term forecast of the factors/variables
influencing the industry. The market segments and
their respective estimates forecasts have been
covered under the quantitative information
category. Forecasts trend analysis for each
country and region is also available in the
study. The report concludes by providing
competitor analysis for major market participants
profiled by analysing their organic inorganic
growth strategies, regional presence, and product
portfolio among others.
Vendor Landscape Pharmacogenomics Market The
report contains a chapter dedicated to vendors
operating in the market, covering raw material
manufactures, equipment developers,
manufacturers, and distributors. The report
provides these insights on a regional level. This
section of the report entails contact details,
experience, products manufactured/supplied, and
geographical presence of companies.
2
GLOBAL MARKET ESTIMATES RESEARCH
CONSULTANTS End-User Landscape (Consumer
Profile) Pharmacogenomics Market The report
provides a detailed list of end-users operating
across the world. The end-user landscape
includes consumer contact details, geographical
presence, revenue, product portfolio, organic
and inorganic growth strategies among others.
Competitor Analysis Pharmacogenomics Market The
major companies profiled in the pharmacogenomics
market include Affymetrix, Inc., AstraZeneca
plc, Bristol-Myers Squibb Company, F. Hoffmann-La
Roche Ltd., Bayer AG, Merck Co., Inc.,
GlaxoSmithKline plc, Johnson Johnson, Myriad
Genetics, Inc., Abbott Laboratories, Inc., and
Teva Pharmaceuticals among others. Companies are
investing in innovation/RD, brand building, and
fostering strong relationships with customers to
enhance their competitive position.

• This article contains text from the
  Pharmacogenomics Market Size, Share, Analysis
  Forecasts To 2025 report prepared by Global
  Market Estimates. For more information or to buy
  the report, please visit https//www.globalmarke
  testimates.com/pharmacogenomics-market/
• Check our annual research partnership service at
• https//www.globalmarketestimates.com/annual-resea
  rch-partnership-services/